0001179110-16-024907.txt : 20160517 0001179110-16-024907.hdr.sgml : 20160517 20160517184058 ACCESSION NUMBER: 0001179110-16-024907 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160513 FILED AS OF DATE: 20160517 DATE AS OF CHANGE: 20160517 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE INC DATE OF NAME CHANGE: 19940719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAFFIERI MICHAEL DAVID CENTRAL INDEX KEY: 0001604063 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 161658913 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 4 1 edgar.xml FORM 4 - X0306 4 2016-05-13 0 0000927066 DAVITA HEALTHCARE PARTNERS INC. DVA 0001604063 STAFFIERI MICHAEL DAVID C/O DAVITA HEALTHCARE PARTNERS INC. 2000 16TH STREET DENVER CO 80202 0 1 0 0 COO, Kidney Care Common Stock 2016-05-16 4 S 0 4934 75.6884 D 12279 D Stock Appreciation Rights 75.42 2016-05-13 4 A 0 66477 0 A 2019-05-13 2021-05-13 Common Stock 66477 66477 D Represents the weighted average sale price of $75.6884. The range of prices for the sale of these shares was $75.22 - $75.91, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This amount includes 330 shares acquired under Issuer's employee stock purchase plan on 12/31/2015. The Stock Appreciation Rights were granted on 5/13/2016. 50% will vest on 5/13/2019 and the remaining 50% will vest on 5/13/2020. /s/ Arturo Sida, Attorney-in-Fact for Michael D. Staffieri 2016-05-17